Ocular Biometry in Vision Screening
DESCRIPTION: The National Children's Eye Care Program has produced a mandate to
screen the vision of all children by the age of four within the next ten years.
This could dramatically effect the treatment of amblyopia and other child
development problems, e.g., reading and learning. Vision anomalies are readily
corrected at the infant and early adolescent ages. Thus, instruments are needed
to provide the screening data such as: refraction/accommodation and strabismus.
AMT Technologies (AMT) has developed an enabling technology, the Ocular
Biometer (OB), that provides the wavefront sensing capability as well as
refraction/accommodation, strabismus, acuity integrated into one instrument.
The OB will be inexpensive, easy to operate by non-medical personnel, have
structural integrity and be as compact and portable. It typically requires a
minute of "face time" to take measurements and provide results requiring no
cycloplegic drugs or medical professional This SBIR proposal Phase I effort is
to perform laboratory tests with prototypes of the Ocular Biometer to verify
the models and analysis. The result of Phase I will be a comprehensive
definition of the Phase II clinical trials. In Phase II extended clinical
trials will be perfonned in cooperation with the Jules Stein Eye Institute on
the University of Califomia campus in Los Angeles.
PROPOSED COMMERCIAL APPLICATION: NOT AVAILABLE
Small Business Information at Submission:
Principal Investigator:Howard P. Apple
AMT TECHNOLOGIES CORPORATION
711 LINDA FLORA DR LOS ANGELES, CA 90049
Number of Employees: